Navigation Links
Challenges With Planning and Generation of Development Safety Update Reports (DSURs) and How to Overcome Them, New Life Science Webinar Hosted by Xtalks
Date:10/25/2013

Toronto, Canada (PRWEB) October 25, 2013

The Development Safety Update Report (DSUR) is an aggregate safety report covering drugs, biologics, vaccines or combo products, whose format is harmonized by ICH E2F guideline The DSUR is accepted in most countries worldwide. It replaces the EU Annual Safety Report and the IND Annual Report. These former reports were not as complex as the DSUR. Because of that complexity an intensive training of staff responsible for generation of DSURs is highly recommended. In the training special attention is to be paid to the definition of the Development International Birthdate (DIBD) and the reporting period, the programming of line listings and summary tabulations, correct categorization of ongoing and completed clinical trials as well as on risk analysis and risk-benefit considerations.

In this webinar attendees will learn about the importance of early and careful planning of all activities related to the generation and submission of DSURs, which includes resource planning. The DSUR contains some unblinded data, which is an additional challenge for smaller companies as personnel involved in the conduct of ongoing studies may not be involved in the DSUR preparation or review. Finally the speaker will share guidance for the review of the draft report ensuring that the final DSUR not only meets regulatory requirements, but is also a useful tool to understand the benefit-risk profile of your compound and a valuable data source for its further development.

For more information about this event or to register, visit: http://xtalks.com/Challenges-with-Development-Safety-Update-Reports.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Day Two of AdvaMed 2013 to Feature Government and Industry Leaders on MedTech Challenges and Opportunities
2. Top 3 Business Development Challenges in Chemicals Addressed in SpecialChem White Paper
3. Women in Science Grant Challenges Status Quo Animal Research
4. 6th BSMA Annual Executive Summit to Address the Supply Chain Challenges and Solutions of Biopharma
5. Addressing Scientific and Regulatory Challenges for Abuse Liability Studies, New Life Science Webinar Hosted by Xtalks
6. Universal Stem Cell Product Could Overcome Key Challenges in Donor Organ Transplants
7. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
8. New York Blood Centers Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
9. Challenges and Solutions in Conducting Biosimilar Trials, New Life Science Webinar Hosted by Xtalks
10. MBC Helps Internal Medicine Specialists in Florida Tackle Medicare & Medicaid Fee Parity Initiative Challenges
11. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Tris Pharma, a specialty pharmaceutical ... announced that it has been selected as an award ... 2014 Awards for Excellence competition in the ... panel of judges from SCORE (Counselors to America,s Small ... be honored at a gala event to be held ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
(Date:8/27/2014)... August 27, 2014 WriteResult, LLC – ... has once again shown superiority when it comes to ... completing the ePRO portion of their most recent study ... Japan-based pharma chose WriteResult’s digital writing platform to collect ... the first to complete drew data from a number ...
(Date:8/26/2014)... , Aug. 26, 2014  NeuroSigma, Inc., a ... to develop bioelectronic technologies, today announced that it has ... U.S. Securities and Exchange Commission relating to a proposed ... of shares to be offered and the price range ... Jefferies LLC will act as the book-running ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
... Research Inc., (TSX:,ARI), a biotechnology company discovering and ... its financial and operational,results for the third quarter, ... of fiscal 2007 was one of preparation as ... into human clinical trials in,2008, while also building ...
... N.C., Oct. 12 Campbell Alliance, the leading,management ... today announced that Ben Bonifant, Vice President,of the ... at the Licensing Executive Society (LES) Annual Meeting. ... at the Vancouver Convention and,Exhibit Centre in Vancouver, ...
... 12 QuantiFERON(R)-TB Gold,In- Tube is Poised to ... for,Accurate & Effective Tuberculosis Screening October 12 ... controllers around the,country can now quickly and accurately ... Drug Administration (FDA) approval of,QuantiFERON(R)-TB Gold In-Tube (QFT(TM)). ...
Cached Biology Technology:ARIUS Announces Third Quarter Fiscal 2007 Financial Results 2ARIUS Announces Third Quarter Fiscal 2007 Financial Results 3ARIUS Announces Third Quarter Fiscal 2007 Financial Results 4ARIUS Announces Third Quarter Fiscal 2007 Financial Results 5ARIUS Announces Third Quarter Fiscal 2007 Financial Results 6ARIUS Announces Third Quarter Fiscal 2007 Financial Results 7ARIUS Announces Third Quarter Fiscal 2007 Financial Results 8ARIUS Announces Third Quarter Fiscal 2007 Financial Results 9ARIUS Announces Third Quarter Fiscal 2007 Financial Results 10ARIUS Announces Third Quarter Fiscal 2007 Financial Results 11ARIUS Announces Third Quarter Fiscal 2007 Financial Results 12ARIUS Announces Third Quarter Fiscal 2007 Financial Results 13ARIUS Announces Third Quarter Fiscal 2007 Financial Results 14ARIUS Announces Third Quarter Fiscal 2007 Financial Results 15Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver 2Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver 3Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis 2Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis 3
(Date:8/27/2014)... advocates, campaigns against trans-fats have largely succeeded in ... aim at sugar for its potential contributions to ... still wrangling over the best way to assuage ... article in Chemical & Engineering News ... Chemical Society. , In the article, Stephen Ritter, ...
(Date:8/27/2014)... factors thought to be associated with outcomes after ... age of the patient, mechanism of injury, nerve ... method, operation technique, and repair materials. However, despite ... peripheral nerve injuries, there is no agreement regarding ... the dose-effect relationship of the predictors has not ...
(Date:8/27/2014)... hours ago the Happy Camp Complex of fires had ... July complex had consumed 35,530 as of eight hours ... the Happy Camp Ranger District of the Klamath National ... August 11, 2014. All but three of those fires ... list of contained fires and their size at containment: ...
Breaking Biology News(10 mins):Happy Camp and July Fire Complexes in California 2
... a heart attack. But the damage to heart muscle is ... the most common cause of death in developed countries. ... body can,t do: mending broken hearts. Engineers and physicians at ... the growth and integration of stem cell-derived cardiac muscle cells. ...
... RIVERSIDE, Calif. Anthony Norman , a ... policy changes regarding people,s vitamin D daily intake ... to reducing the frequency of many diseases, including ... hypertension, cardiovascular disease, obesity and muscle weakness. ...
... German . , Those who have to fight ... physicists from different scientific fields have decided to cooperate with ... through heat treatment by means of magnetic nanoparticles on a ... to improve the success of the therapy. Within the scope ...
Cached Biology News:A strategy to fix a broken heart 2A strategy to fix a broken heart 3Biochemist proposes worldwide policy change to step up daily vitamin D intake 2Biochemist proposes worldwide policy change to step up daily vitamin D intake 3How many nanoparticles heat the tumor? 2How many nanoparticles heat the tumor? 3
Rabbit Serum New Zealand or California Origin...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... be returned to customer conjugation of peptide to KLH protein ... 102 days/each , Pre-immune bleed x1 /each ... , Test bleed (app. 5 ml) x1 /each ...
...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
Biology Products: